Lazard Capital Starts Apricus Biosciences (APRI) at Buy
Tweet
Share
E-mailGet Alerts APRI Hot Sheet
Price: $0.22 --0%
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Lazard Capital initiates coverage on Apricus Biosciences (NASDAQ: APRI) with a Buy. PT $8.00.
For an analyst ratings summary and ratings history on Apricus Biosciences click here. For more ratings news on Apricus Biosciences click here.
Shares of Apricus Biosciences closed at $3.12 yesterday.
For an analyst ratings summary and ratings history on Apricus Biosciences click here. For more ratings news on Apricus Biosciences click here.
Shares of Apricus Biosciences closed at $3.12 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- Citi Starts Federal Signal (FSS) at Buy
- ThinkEquity Starts Deep Isolation Nuclear (DBHL) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
